These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5036166)

  • 21. N-Fluoroacetyl-D-glucosamine as a molecular probe of lysozyme structure using ( 19 F)fluorine-nuclear-magnetic resonance techniques.
    Dwek A; Kent PW; Xavier AV
    Eur J Biochem; 1971 Nov; 23(2):343-8. PubMed ID: 5156376
    [No Abstract]   [Full Text] [Related]  

  • 22. The binding of boronic acids to chymotrypsin.
    Rawn JD; Lienhard GE
    Biochemistry; 1974 Jul; 13(15):3124-30. PubMed ID: 4858346
    [No Abstract]   [Full Text] [Related]  

  • 23. Reactions of alpha-chymotrypsin with 4-(trifluoromethyl)-alpha-bromoacetanilide.
    Ando ME; Gerig JT
    Biochemistry; 1982 May; 21(10):2299-304. PubMed ID: 7093189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the catalytic mechanism of pepsin using a new synthetic substrate.
    Hunkapiller MW; Richards JH
    Biochemistry; 1972 Jul; 11(15):2829-39. PubMed ID: 4557517
    [No Abstract]   [Full Text] [Related]  

  • 25. Investigation of the mechanism of ligand binding with cobalt(II) human carbonic anhydrase by 1 H and 19 F nuclear magnetic resonance spectroscopy.
    Taylor PW; Feeney J; Burgen AS
    Biochemistry; 1971 Oct; 10(21):3866-75. PubMed ID: 5003665
    [No Abstract]   [Full Text] [Related]  

  • 26. N-[2,2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of alpha-chymotrypsin.
    Iijima K; Katada J; Yasuda E; Uno I; Hayashi Y
    J Med Chem; 1999 Jan; 42(2):312-23. PubMed ID: 9925737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-chymotrypsin: effects of bicyclic substrate geometry and hydrophobicity on reactivity.
    Matta MS; Rohde MF
    Arch Biochem Biophys; 1973 Nov; 159(1):550-4. PubMed ID: 4784474
    [No Abstract]   [Full Text] [Related]  

  • 28. Complex of alpha-chymotrypsin and N-acetyl-L-leucyl-L-phenylalanyl trifluoromethyl ketone: structural studies with NMR spectroscopy.
    Liang TC; Abeles RH
    Biochemistry; 1987 Dec; 26(24):7603-8. PubMed ID: 3427096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of small molecules to proteins.
    Bothner-By AA; Gassend R
    Ann N Y Acad Sci; 1973 Dec; 222():668-76. PubMed ID: 4522439
    [No Abstract]   [Full Text] [Related]  

  • 30. Fluorescence and 19F NMR evidence that phenylalanine, 3-L-fluorophenylalanine and 4-L-fluorophenylalanine bind to the L-leucine specific receptor of Escherichia coli.
    Luck LA; Johnson C
    Protein Sci; 2000 Dec; 9(12):2573-6. PubMed ID: 11206079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trifluoroacetylated peptides as substrates and inhibitors of elastase: a nuclear magnetic resonance study.
    Dimicoli JL; Bieth J; Lhoste JM
    Biochemistry; 1976 May; 15(10):2230-6. PubMed ID: 1276135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMR studies of the alpha-chymotrypsin-(R)-1-acetamido-2-(4-fluorophenyl)ethane-1-boronic acid complex at pH 7.
    Sylvia LA; Gerig JT
    Biochim Biophys Acta; 1995 Oct; 1252(2):225-32. PubMed ID: 7578227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzyme--substrate interaction by nuclear magnetic resonance.
    Spotswood T; Evans JM; Richards JH
    J Am Chem Soc; 1967 Sep; 89(19):5052-4. PubMed ID: 6074810
    [No Abstract]   [Full Text] [Related]  

  • 34. Correlation of low-barrier hydrogen bonding and oxyanion binding in transition state analogue complexes of chymotrypsin.
    Neidhart D; Wei Y; Cassidy C; Lin J; Cleland WW; Frey PA
    Biochemistry; 2001 Feb; 40(8):2439-47. PubMed ID: 11327865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noncovalent inhibition of the serine proteases, alpha-chymotrypsin and trypsin by trifluoro(organo)borates.
    Smoum R; Rubinstein A; Srebnik M
    Org Biomol Chem; 2005 Mar; 3(5):941-4. PubMed ID: 15731882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urea denaturation of active-site spin-labeled -chymotrypsin.
    Berliner LJ
    Biochemistry; 1972 Jul; 11(15):2921-4. PubMed ID: 4339473
    [No Abstract]   [Full Text] [Related]  

  • 37. Fluorine-19 nuclear magnetic resonance studies of effects of ligands on trifluoroacetonylated supernatant aspartate transaminase.
    Critz WJ; Martinez-Carrion M
    Biochemistry; 1977 Apr; 16(8):1559-64. PubMed ID: 15584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorine nuclear magnetic resonance spectra of rabbit carbonmonoxyhemoglobin.
    Gamcsik MP; Gerig JT; Gregory DH
    Biochim Biophys Acta; 1987 Apr; 912(3):303-16. PubMed ID: 3567201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorine-NMR studies of chimpanzee hemoglobin.
    Gamcsik MP; Gerig JT; Swenson RB
    Biochim Biophys Acta; 1986 Dec; 874(3):372-4. PubMed ID: 3790577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferential binding of competitive inhibitors to the monomeric form of -chymotrypsin.
    Nichol LW; Jackson WJ; Winzor DJ
    Biochemistry; 1972 Feb; 11(4):585-91. PubMed ID: 5011966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.